NYSE:CVD - Covance Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $107.07 0.00 (0.00 %) (As of 07/22/2018 10:58 AM ET)Previous Close$107.07Today's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket Capitalization$6.06 billionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Covance Inc. is engaged in drug development services. The Company provides a range of early-stage and late-stage product development services to the pharmaceutical and biotechnology industries. The Company also provides laboratory testing services to the chemical, agrochemical and food industries. The Company operates in two segments: early development services, and late-stage development services. The early development services include lead optimization services, preclinical services and clinical pharmacology services. The late-stage development services include central laboratory, Phase II-IV clinical development, and market access services. Receive CVD News and Ratings via Email Sign-up to receive the latest news and ratings for CVD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryLife Sciences Tools & Services SectorN/A SymbolNYSE:CVD CUSIP22281610 Webwww.covance.com Phone+1-609-4524440 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins7.70% Return on Equity12.64% Return on Assets8.17% Miscellaneous EmployeesN/A Outstanding SharesN/AMarket Cap$6,060.00 Covance (NYSE:CVD) Frequently Asked Questions What is Covance's stock symbol? Covance trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVD." How were Covance's earnings last quarter? Covance Inc. (NYSE:CVD) announced its earnings results on Wednesday, February, 4th. The healthcare company reported $0.97 EPS for the quarter, hitting the consensus estimate of $0.97. The healthcare company earned $634 million during the quarter, compared to analysts' expectations of $631.30 million. Covance had a net margin of 7.70% and a return on equity of 12.64%. View Covance's Earnings History. What is the consensus analysts' recommendation for Covance? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covance in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has Covance been receiving favorable news coverage? Media headlines about CVD stock have trended somewhat positive recently, according to Accern. The research firm identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Covance earned a news impact score of 0.12 on Accern's scale. They also gave news coverage about the healthcare company an impact score of 44.19 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. How do I buy shares of Covance? Shares of CVD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Covance's stock price today? One share of CVD stock can currently be purchased for approximately $107.07. How big of a company is Covance? Covance has a market capitalization of $6.06 billion. How can I contact Covance? Covance's mailing address is 210 Carnegie Ctr, PRINCETON, NJ 08540-6233, United States. The healthcare company can be reached via phone at +1-609-4524440. MarketBeat Community Rating for Covance (NYSE CVD)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 173 (Vote Outperform)Underperform Votes: 206 (Vote Underperform)Total Votes: 379MarketBeat's community ratings are surveys of what our community members think about Covance and other stocks. Vote "Outperform" if you believe CVD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What does earnings per share mean?